drugset / Trial / NCT00644800
A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
To assess the efficacy, safety, and tolerability of intramuscular ziprasidone in the treatment of the acute exacerbation of non-organic psychosis of any etiology, including schizophrenia, acute mania, delusional disorder and others.
Timeline
- Start
- 2003-07
- Primary completion
- —
- Completion
- 2004-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ziprasidone | Small molecule | 40 mg | Intramuscular |
| Subject | Ziprasidone | Small molecule | 80 mg | Intramuscular |